跳至主要内容
临床试验/NL-OMON40238
NL-OMON40238已完成不适用

The Effect of Creatine Supplementation on Muscle Loss During Immobilisation - Creatine and disuse atrophy

niversiteit Maastricht0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Aged from 18-35 years
  • 18.5 < BMI < 30 kg/m2

排除标准

  • (Family) history of thrombosis
  • Recent surgery < 6 months
  • Performing regular resistance training more than once per week in the past year
  • Any back/leg/knee/shoulder complaints which may interfere with the use of crutches
  • Current systemic use of corticosteroids, growth hormone, testosterone, immunosuppressants or insulin
  • All co-morbidities interacting with mobility and muscle metabolism of the lower limbs (e.g. arthritis, spasticity/rigidity, all neurological disorders and paralysis)
  • Use of anti-coagulants
  • Pre-existing renal disease or those with a potential risk for renal dysfunction (diabetes, hypertension, reduced glomerular filtration rate)

研究者

相似试验